Company ProfilePremium

Litigation Capital Management Limited

Company Profile Analysis

Ticker: LIT.L

ESOMAR 23 Corporate BadgeISO Certifications Badge
Litigation Capital Management Limited - Company showcase

Year Founded & Workforce

2001

Litigation Capital Management Limited logo

Litigation Capital Management Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Litigation Capital Management Limited Overview

Litigation Capital Management is an Australian-domiciled, AIM-listed disputes financier. For over two decades it funded commercial litigation, class actions, insolvency claims and international arbitration in Australia, the UK and Asia. From 2020 it moved towards an asset-management model, raising US$441m across two private funds, and pitched itself as a premium, actively managed alternative to lawyer-led funders. That model has now failed. Across FY2025 and FY2026 a cluster of large, concentrated case losses wiped out A$238.6m of after-tax earnings. A performance-fee clawback provision and uninsured adverse costs added to the damage. Net assets swung from A$188.9m at June 2024 to net liabilities of A$53.6m at June 2026. A strategic review produced no transaction. The company is now a lender-controlled run-off vehicle: a 37-case portfolio is being worked out for the benefit of Northleaf, whose amended facility must be repaid in full, at a minimum of twice drawn principal, before shareholders can receive anything.


Company's own description

In its FY2026 results, LCM describes itself as a disputes financing business that has funded claimants internationally through direct balance-sheet investments and third-party funds under management. Following the strategic review, it states that the existing portfolio will be managed to conclusion, no new investments will be made, and realised cash will be applied to repaying the debt facility.

Until FY2025 the company's standard description was "an alternative asset manager specialising in disputes financing solutions internationally" with two business models (balance sheet and third-party fund management) and three strategies (single-case funding, portfolio funding and acquisitions of claims).

Business model (historical, as it operated to FY2025)

Direct investments (balance sheet): LCM paid the legal costs, expert fees and often adverse-cost insurance premiums of a claimant. In return it received a share of the award or settlement, or a multiple of deployed capital, plus reimbursement of invested capital. If the case lost, the investment went to zero, and adverse-cost exposure was covered by after-the-event (ATE) insurance where purchased.

Fund management: From 2020, new cases were typically co-funded 25% from LCM's balance sheet and 75% from third-party funds (Fund I and Fund II). LCM earned performance fees on fund realisations above hurdles. Fund I paid LCM US$28.9m of performance fees on early realisations, and these are now subject to a clawback provision.

Risk management services: LCM described "litigation finance and risk management" as its principal activity, including portfolio solutions for corporates and insolvency practitioners.

Revenue model

Income line (LCM-only basis)Nature
Net realised gains/losses on concluded investmentsProceeds on LCM capital, less capital invested, on cases that conclude
Performance fees on third-party capitalCarried interest from Funds I and II (negative in FY26 owing to a A$27.0m reversal and clawback)
Net fair value movementMark-to-model changes on ongoing cases (IFRS 9, Level 3, DCF with milestone risk adjustments)
Litigation service revenue / expenseLegacy cases held at contract cost under AASB 15
Other incomeFund expense reimbursements

Income is almost entirely investment-return driven. There are no product, subscription or licensing revenues.

Value chain position, customers and end-markets

LCM sits between claimants and their lawyers on one side and capital providers (its own shareholders, fund LPs and its lender) on the other. Its customers were:

  • corporate claimants in commercial disputes;

  • investors bringing investment-treaty claims against sovereign states (for example Green-X Metals against Poland, and a claim against Tanzania);

  • class action group members in Australia and the UK;

  • insolvency practitioners and liquidators;

  • competition (antitrust) claimants;

  • IP owners, including a US IP case.

Independent characterisation

LCM was a sub-scale, concentrated single-case funder that layered a fund-management model on top of a small balance sheet and then added senior secured leverage. The company itself says three cases made up most of its balance-sheet invested capital at June 2025, and that by FY2026 losses were compounded by concentration in a small number of large cases. The asset-management pivot raised fee-earning capital but did not diversify the balance sheet enough to absorb binary losses. The CEO conceded in FY2025 that the investment process had drifted towards a lawyer-led approach as he shifted his focus to fundraising. In its current form LCM is a liquidating portfolio whose equity is deeply subordinated to a payment-in-kind (PIK), limited-recourse lender claim.

Strategy

Strategic arc

PeriodStated strategy themes
FY2020–FY2024Transition to asset management (25% balance sheet / 75% funds); grow funds under management; London and Asia-Pacific origination; fair value accounting to show embedded value; capital returns; Fund III; staged US entry
FY2025"Refocused investment strategy" and return to hands-on active case management; decisive exits from underperformers; sizing discipline to manage concentration; independent quantitative scrutiny of expert evidence; cost base halved; strategic review benchmarked against "lean run-off"
FY2026 (current)Orderly run-off under a Northleaf-approved business plan; no new investments (not contemplated and not permitted under the Northleaf agreement); cash applied first to the facility; further cost reductions

Initiatives in the last 24 months

InitiativeDateStatus / outcome
Fund III fundraiseMarketing from late 2024First close expected May 2025; suspended after Dubai media reports; abandoned
US market entryAnnounced September 2024Not executed
Fair value model recalibration (lower profit assumptions for group claims, longer durations, slower risk-adjusted recognition; appeal losses held at 50–60% of cost)FY2025Implemented; annual review instituted
Cost reduction programmeFrom H2 FY2025Operating expenses A$19.0m (FY24) to A$18.0m (FY25) to A$11.0m (FY26); further cuts promised in run-off
Portfolio re-underwriting and selective exits (for example Gladstone)FY2025–FY2026Ongoing cases reduced from 53 to 37
Strategic review (Luminis)15 Sep 2025 – 30 Sep 2026Concluded with no transaction
Recovery actions against Gladstone solicitors (costs assessment; negligence and breach-of-contract claim)From September 2025Outcome not disclosed
Legal options against UAE authorities over the leaked Dubai probeAnnounced October 2025Under review
ESG / sustainability commitments——

Guidance / medium-term targets

LCM gives no numerical guidance. Its implicit objective is to realise the portfolio and repay Northleaf. The first financial covenant test under the amended facility falls on 31 December 2027.

Products & Services

LCM sells no physical products. The catalogue below covers its financing strategies, case types and fund vehicles. All are now closed to new business under run-off.

Investment strategies

OfferingDescriptionTarget customerLaunch / statusPricing model
Single-case fundingFinances one dispute: legal fees, experts, sometimes ATE premiumsCorporate claimants, treaty claimants, class action groupsSince inception (1998 predecessor); the largest strategyPercentage of proceeds or multiple of capital deployed, plus return of capital
Portfolio fundingFinances a bundle of disputes for a law firm, insolvency practitioner or corporate, with cross-collateralisationCorporates (main focus), law firms, insolvency practitionersDeveloped over the 2010s–2020s; closed under run-offPortfolio-level return; terms not publicly disclosed
Acquisition of claimsBuys or takes assignment of smaller (typically insolvency) causes of action and pursues recovery as principalLiquidators and administrators"Early stages of evolution" per FY25 and H1 FY26 reports; closed under run-offPrincipal recovery
Disputes risk managementRisk management and financing products for disputes, including adverse-cost cover structuringClaimants and corporatesDescribed as a principal activity; no standalone revenue disclosed—

Case types funded (from FY2025 concluded-case table and RNS)

Case typeNamed / disclosed examplesNotes
Investment treaty arbitrationGreen-X Metals v Poland (ECT and Australia–Poland BIT awards); claim against TanzaniaFY25 treaty wins returned 9.0x and 6.8x MOIC. Green-X v Poland contributed A$26.1m of net realised gains and Tanzania A$12.0m
Commercial arbitrationUK commercial arbitration (A$5.3m, lost, appeal); commercial arbitration lost 1 April 2025 (A$2.6m)Mixed outcomes
Commercial litigation (UK)UK commercial claim with A$20.6m of LCM capital, co-funded with Fund I, lost at High Court 1 October 2025Held at £26.5m (A$55.3m) fair value at 30 June 2025 per press reports
Commercial litigation (Australia)Trademark dispute won in the High Court of Australia (A$3.3m invested, March 2026); A$1.4m claim lost 17 March 2026Quantification of damages pending in the trademark matter
Class actions (Australia)Gladstone Ports (terminated, A$30.8m written off); Queensland Electricity (lost, about A$32.4m total adverse costs, A$12.9m uninsured to LCM); Quintis (lost February 2025, appeal)Main source of losses
Class actions (UK)UK class action loss (A$1.0m) in FY25—
CompetitionTwo FY25 losses (A$1.9m and A$1.7m); permission to appeal refused 3 July 2026 (A$1.5m write-off)UK CAT-type claims
InsolvencyAustralian insolvency wins (1.9x and 4.5x MOIC in FY25); US insolvency win (1.5x); Australian insolvency claim lost 8 October 2026 (A$2.9m)Historically high hit rate, small tickets
Intellectual propertyUS IP case lost in FY25 (A$4.5m)Only disclosed US exposure besides insolvency

Fund vehicles

FundSize (external capital)StatusPerformance disclosed
Fund I: LCM Global Alternative Returns FundUS$150mFully committed, 85% deployed (June 2025); 23 investments net of 3 terminations12 concluded (9 wins, 3 losses): gross proceeds US$121.3m on LP capital of US$54.9m; LP net MOIC 1.7x, net IRR 30.4% (to June 2025). LCM received US$28.9m in performance fees; A$20.4m clawback provision raised in FY26
Fund II: LCM Global Alternative Returns Fund IIUS$291m (final close 2023)Closed to new business at about 65% committed; about US$50m deployed (June 2025); 37 cases net of 13 terminations5 concluded (2 wins, 3 losses), aggregate MOIC 0.2x
Fund III—Marketing began late 2024; first close expected early May 2025 but suspended after the Dubai media reports; abandoned in run-off—

Financial Narrative

Income statement: notes and sources

Notes: FY2022 EPS of 32.7c is the restated fair value comparative shown in the FY2023 release, whereas FY2022 PBT of A$10.7m is the original historical-cost figure; the two are on different bases. FY2021 comparatives: revenue A$37.1m, PBT A$12.9m, gross profit A$26.6m. Discrepancy: one press report (QuotedData, October 2025) cited an FY25 post-tax loss of A$79m, but LCM's audited FY25 accounts and FY26 comparatives show A$72.913m; the audited figure is used here. EBITDA is not reported. Because LCM has negligible depreciation (A$0.07m in FY26), operating profit is a close proxy.

Margins (derived, LCM-only basis)

Margins are not meaningful in FY2025 and FY2026 because total income was negative. A revenue CAGR is not meaningful: income turned negative in FY2025.

Balance sheet

Borrowings have no short/long-term split because the balance sheet is presented in order of liquidity. The whole Northleaf facility was a single term facility; after the 30 September 2026 amendment it runs to 31 December 2030. There is no goodwill. Working capital is not presented. The FY2022 equity figure comes from a secondary data provider (Shares Magazine) and its basis (historical-cost versus restated) is unconfirmed.

Ratios (derived)

ROE and debt/equity are not meaningful for FY2026 because equity is negative. Net debt/EBITDA, current ratio, asset turnover, ROIC and cash conversion cycle are not meaningful for a litigation-asset balance sheet presented in liquidity order, and the company does not report them.

Commentary on trends, inflections and drivers

FY2022–FY2023: the scale-up. Assets under management grew from A$336m (FY21) to A$484m (FY23). The FY23 switch to fair value accounting brought forward recognition of unrealised gains. Fund I realisations produced FY23 realised income of A$181m (A$84m attributable to LCM), and LCM cash reached A$83m.

FY2024: the peak. The balance sheet peaked at A$188.9m of net assets. New commitments hit a record A$279m and the company returned A$10.4m via dividends and buybacks while committing heavily. This was the decisive inflection. Capital was being deployed and distributed just as concentration was rising, and a new debt facility followed in December 2024.

FY2025: the first loss year. LCM recorded 6 wins against 6 losses, plus 3 trial losses taken to appeal. Fair value movement swung A$112.6m (from +A$12.5m to -A$100.1m). Net debt rose from A$8.9m to A$68.9m as A$59.8m went into case funding while only A$33.6m came back. The going-concern material uncertainty first appeared here.

FY2026: collapse. Eight investments concluded, seven of them losses. Proceeds on LCM capital were just A$1.1m against A$38.0m of cost. Uninsured adverse costs (A$12.9m on Queensland Electricity), an adverse-costs provision (A$4.2m) and the Fund I clawback provision (A$20.4m) compounded the losses. Finance costs rose 72% to A$12.5m on higher drawings and a 200bp waiver margin. Cost cutting (operating expenses down 39%) was immaterial against portfolio losses.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentContentsProducts / services

LCM

Parent and wholly owned subsidiaries: 100% balance-sheet investments, the 25% co-investment in Funds I and II, and corporate operations

Single-case funding, portfolio funding, claim acquisitions, fund management (performance fees)

Fund (Fund I and Fund II)

LCM Global Alternative Returns Fund and Fund II, consolidated under AASB 10 because LCM controls them; holds the 75% third-party co-investment and fund administration costs

Third-party LP capital deployed alongside LCM

Results by Segment and Revenue by Segment (%)

MetricFY2024FY2025FY2026

LCM segment total income (AUD Mn)

44.718-82.028-152.076

Fund segment total income (AUD Mn)

3.0333.569-0.455

Consolidated total income (AUD Mn)

47.752-78.459-152.531

LCM segment share of consolidated (%)

93.6104.599.7

Revenue by Segment

MetricFY2024FY2025FY2026

LCM net realised gain (AUD Mn)

23.03322.187-63.889

Fund net realised gain (AUD Mn)

38.74421.456-51.879

Consolidated net realised gain (AUD Mn)

61.77843.643-115.768

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Revenue by Segment — LCM net unrealised movement

MetricFY2024FY2025FY2026

LCM net unrealised movement (AUD Mn)

12.477-100.103-54.127

Fund net unrealised movement (AUD Mn)

12.671-106.664-30.542

Income Statement and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Gross profit, historical-cost basis as originally reported, incl. third parties (AUD Mn)

31.1————

LCM-only total income / (loss) (AUD Mn)

—67.744.7-82.0-152.1

Consolidated total income / (loss) (AUD Mn)

——47.752-78.459-152.531

LCM-only net realised gain / (loss) (AUD Mn)

—51.523.022.2-63.9

LCM-only net fair value movement (AUD Mn)

——12.5-100.1-54.1

LCM-only operating expenses (AUD Mn)

——19.018.011.0

Consolidated operating profit / (loss) (AUD Mn)

——26.133-94.392-161.085

Finance costs, consolidated (AUD Mn)

——10.0837.29512.512

Profit / (loss) before tax (AUD Mn)

10.7—16.050-101.687-173.597

Income tax (expense) / benefit (AUD Mn)

——-3.33528.7747.861

Net profit / (loss) after tax (AUD Mn)

—31.512.715-72.913-165.736

Basic EPS (A cents)

32.729.512.01-70.83-160.88

Diluted EPS (A cents)

——11.33-70.83-160.88

Dividend per share declared for the year (GBp)

—2.251.2500

Margin Analysis (%)

MetricFY2023FY2024

Operating margin on LCM total income (%)

—58.8

Pre-tax margin on LCM total income (%)

—35.9

Net margin on LCM total income (%)

46.528.4

Balance Sheet

MetricFY2022FY2023FY2024FY2025FY2026

Total assets, consolidated (AUD Mn)

——591.803445.558274.845

Total assets, LCM-only (AUD Mn)

——314.4214.0107.3

Cash, consolidated (AUD Mn)

50.0104.568.11318.44710.415

Cash, LCM-only (AUD Mn)

29.383.053.08.92.1

Borrowings, total (AUD Mn)

——61.91777.747125.512

Net debt, LCM-only (AUD Mn)

——8.968.9123.4

Investments at fair value, LCM-only (AUD Mn)

——202.9124.862.2

Investments at cost (AASB 15), LCM-only (AUD Mn)

——42.148.018.1

Third-party interests in consolidated funds (AUD Mn)

——264.950226.538177.147

Deferred tax liability (AUD Mn)

——43.62415.2867.425

Intangible assets (AUD Mn)

——0.3050.4390.380

Total equity / (deficit) (AUD Mn)

148.93183.469188.941114.370-53.646

NAV per share, basic (GBp)

—90.394.453.2—

Cash Flow

MetricFY2024FY2025FY2026

Net operating cash flow (AUD Mn)

19.203-80.454-91.857

Proceeds from litigation contracts (AUD Mn)

116.63664.7023.058

Payments for litigation contracts (AUD Mn)

78.265128.16682.315

Capex, PP&E plus intangibles (AUD Mn)

0.0400.2060

Free cash flow, derived OCF less capex (AUD Mn)

19.163-80.660-91.857

Dividends paid (AUD Mn)

4.9762.6800

Share buybacks / treasury shares (AUD Mn)

5.3965.3180

Proceeds from borrowings (AUD Mn)

025.03943.087

Repayment of borrowings (AUD Mn)

8.13912.8640

Dividends & Capital Returns

MetricFY2024FY2025FY2026

Opening cash (AUD Mn)

83.053.08.9

Cash from concluded investments (AUD Mn)

56.733.62.4

Cash invested into ongoing cases (AUD Mn)

-39.7-59.8-37.7

Operating expenses paid (AUD Mn)

-17.0-16.0-11.1

Net finance costs paid (AUD Mn)

-9.0-6.5-3.5

Dividends and buybacks (AUD Mn)

-10.4-8.00.0

Net debt drawdown / (repayment) (AUD Mn)

-8.112.243.1

Closing cash (AUD Mn)

53.08.92.1

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2024FY2025FY2026

ROE, PAT / average equity (%)

6.8-48.1—

ROA, PAT / year-end consolidated total assets (%)

2.1-16.4-60.3

ROA, PAT / year-end LCM-only total assets (%)

4.0-34.1-154.5

Debt / equity (x)

0.330.68—

Interest coverage, operating profit / finance costs (x)

2.6-12.9-12.9

Net debt / LCM-only total assets (%)

2.832.2115.0

Region Assets & Liabilities and Revenue by Region (%)

MetricFY2025H1 FY2026

APAC Level 3 litigation funding assets (AUD Mn)

81.22087.831

EMEA Level 3 litigation funding assets (AUD Mn)

206.515115.898

Total Level 3 assets (AUD Mn)

287.735203.729

APAC share (%)

28.243.1

Share Price History

DatePrice (GBp)Source / context

Pre-1 Oct 2025

26.6

Implied from the 16p fall to 10.6p

1 Oct 2025

10.6

After UK High Court loss (QuotedData)

2 Apr 2026

3.8

Fidelity bid price

Oct 2026

1.53

Stockopedia; market cap about £1.74m

Valuation Multiples

MultipleLCMComment

P/E

n/m

Loss-making. Stockopedia's displayed trailing P/E of 1.55 appears to be a data error and should be disregarded

P/B

n/m

Negative book value

EV/Sales, EV/EBITDA

n/m

Negative income

Analyst consensus

Stockopedia shows a "Buy" consensus with a 104.15p target

Clearly stale (pre-collapse); treat as unreliable

Dividends & Capital Returns (FY2023–FY2026)

MetricFY2023FY2024FY2025FY2026

Dividend declared per share (GBp)

2.251.2500

Dividends paid (AUD Mn)

—4.9762.6800

Buyback / treasury share purchases (AUD Mn)

—5.3965.3180

Capital Markets

ItemDetail

Facility

Northleaf senior secured term facility (Facility B of the Amended and Restated Senior Term Facility Agreement)

Limit

US$125m (from US$100m), subject to conditions precedent

Maturity

31 December 2030

Pricing

SONIA + 1,000bp, fully PIK (previously 525bp plus 200bp during waivers)

Repayment

Greater of (i) principal plus capitalised interest or (ii) 2x principal drawn

Upside sharing

25% of gross cash proceeds of remaining investments (including fund performance fees) if repaid before the portfolio concludes

Recourse

Limited recourse to the case portfolio

Covenants

New run-off covenants; first test 31 December 2027

Carrying amount

A$125.5m at 30 June 2026

Analyst Conclusions

Management guidance

No financial guidance is given. Management's plan is to manage the 37-case portfolio to conclusion under a business plan approved by Northleaf, cut costs further and apply all realisations to the facility. No sell-side consensus is credible or current.

Bull case

  1. Appeal reversals. Four cases lost at first instance (A$66m invested) are carried at only A$33m. Successful appeals would lift asset values materially.

  2. Large receivables crystallise. The Green-X v Poland awards survived a Singapore set-aside challenge, and LCM-only receivables are A$21.2m. Collection, plus trademark damages, would bring in cash at low cost.

  3. Side recoveries. The Gladstone solicitor recovery, a possible Dubai compensation claim and A$62.3m of unrecognised tax losses offer non-portfolio upside.

Bear case

  1. The lender's claim compounds faster than assets realise. At FY26, LCM-only total assets were A$107.3m against total liabilities of A$160.9m. PIK interest at SONIA + 10% and the 2x-principal floor make the hurdle before any equity value very high.

  2. The loss rate has not normalised. Seven of eight FY26 conclusions were losses, and further losses followed after year-end (July and October 2026).

  3. Contingent liabilities are larger than provided for. These include clawback (A$20.4m provided), under-insured adverse costs (A$4.2m provided against a A$4–8m contingent range) and going-concern conditions precedent.

Catalysts and monitorables (next 12 months)

  • Satisfaction of the remaining conditions precedent to the Northleaf amendment.

  • Appointment of the two Northleaf-nominated directors at LCM Group Holdings.

  • Appeal outcomes on the four cases lost at first instance.

  • Collection progress on the Poland awards and any further set-aside rulings.

  • Damages quantification in the trademark case.

  • FY26 annual report, AGM (late November 2026) and any resolutions on the company's listing status.

  • H1 FY27 results (about March 2027): cash realised versus PIK accrual.

  • Final crystallisation of the Fund I clawback.

  • Further adverse-costs awards.

Analyst verdict

Litigation Capital Management is no longer an operating litigation financier in any forward-looking sense. It is a lender-controlled liquidation of a damaged portfolio. The numbers leave little room for interpretation. Two consecutive years of losses (A$72.9m and A$165.7m) consumed the entire equity base and left net liabilities of A$53.6m. Cash generation from concluded investments fell to A$2.4m in FY26 while A$37.7m was still being deployed. The strategic review, despite talks with "credible counterparties", produced no transaction. The board has instead accepted Northleaf terms that are punitive by design: fully PIK interest at SONIA plus 1,000bp, repayment of at least twice drawn principal, 25% of residual proceeds after repayment, limited recourse, and lender-nominated directors at the operating subsidiary.

The causes are clear from LCM's own admissions: concentration in a handful of large class actions and commercial claims, escalating commitments to failing cases, weak scrutiny of expert evidence, and leverage added near the top of the cycle. Fair value accounting magnified the optics on the way up and reversed sharply on the way down. In FY25, cases held at 2.8x cost before conclusion realised 1.8x.

For shareholders, the relevant question is no longer earnings or valuation multiples. It is whether portfolio realisations can exceed the lender's compounding claim by a wide enough margin to leave any residual. On current disclosures that looks remote. Appeal reversals and the Polish awards provide genuine but limited optionality. The roughly £1.7m market capitalisation prices this as a deep out-of-the-money call. For creditors and fund LPs the story is recovery management. For the sector, LCM is a case study in the risks of combining single-case binary exposure, small scale and senior debt.

Verdict: Equity is speculative and effectively subordinated to the lender. The dossier assigns no fundamental value to the shares beyond option value, and rates the business as being in terminal run-off.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameRoleTenure / background (as disclosed)Shareholding (Simply Wall St, c. June 2025)

Jonathan Moulds

Non-Executive Chairman

Chair through the AIM era; signs the FY25 Chairman's statement and interim reports. Prior roles and education not disclosed in sources reviewed

5,250,000 (5.04%)

Patrick Moloney

Chief Executive Officer, Executive Director

Long-standing CEO; built the track record from the predecessor business; led the AIM listing, fund strategy and run-off

11,870,122 (11.4%)

Dr David King

Non-Executive Director

Details not disclosed in sources reviewed

1,951,484 (1.87%)

David Collins

Chief Financial Officer, Executive Director

CFO with "more than 12 months in the role" by October 2025; appointed to the Board 6 December 2024; led the fair value model review

—

“—” = not publicly disclosed.

Board & Management Changes

DateChange

6 Dec 2024

CFO David Collins joins the Board

FY2025

Gerhard Seebacher steps down as Non-Executive Director after more than four years

2025

Two of three former senior NEDs gone; the Board shrinks to 2 non-executives and 2 executives

30 Sep 2026 (pending)

Two Northleaf-nominated independent directors to join the board of subsidiary LCM Group Holdings Pty Ltd, through which all investments are held

Directors' Remuneration

MetricFY2025FY2026

Salaries and wages (AUD K)

8,4315,191

Severance payments (AUD K)

591617

Non-executive directors' fees (AUD K)

420349

Share-based payments expense (AUD K)

1,117563

Major Shareholders

HolderSharesStake (%)

Collins St Asset Management Pty Ltd

14,869,81614.3

Patrick Moloney

11,870,12211.4

Jonathan Moulds

5,250,0005.04

Tectonic Investment Management Pty Ltd

4,908,6594.71

Pendal Group (Perpetual)

3,489,6883.35

David King

1,951,4841.87

Aberdeen Group plc

1,859,2021.79

Michael Barben

913,2390.88

BN & Partners Capital AG

224,9620.22

Mary Gangemi

64,3480.06

Competitive Landscape

Key Competitors

CompetitorListing / typeOverlap with LCMRelative positioning

Burford Capital

NYSE / LSE (BUR)

Global commercial, treaty and corporate portfolio funding

Market leader by scale; YPF exposure; appeal decision announced March 2026

Omni Bridgeway

ASX (OBL)

Australian class actions, insolvency, global commercial

Direct Australian rival; FY26 statutory NPAT A$45.9m; debt-free; AuM over A$5.9bn

Manolete Partners

AIM (MANO)

UK insolvency claims acquisition

Overlaps the "acquisition of claims" strategy

Harbour Litigation Funding

Private (UK)

UK commercial and group actions

Larger UK specialist

Therium Capital

Private (UK)

UK and international commercial

Peer; LCM's CEO notes several peers have ceased operations

Woodsford

Private (UK)

UK collective (competition) actions

Competition-claim rival

Bench Walk Advisors

Private (US/UK)

Commercial and arbitration

Fund-model peer

Fortress Investment Group (legal assets)

Private

Large-ticket legal assets

Deep-pocketed capital provider

Longford Capital

Private (US)

US commercial / IP

Relevant to LCM's abortive US plans

Deminor

Private (EU)

Arbitration and enforcement

EMEA competitor

CASL / Australian class action funders

Private (AU)

Australian class actions

Domestic competition

Peer Comparison FY2026

MetricLCM (FY26, A$)Omni Bridgeway (FY26, A$)Burford (FY24, US$)

Net profit / (loss) (m)

-165.745.9146.5

Total income / revenue (m)

-152.1—472.3

AuM / FuM

US$339m FuM (FY25)

over A$5.9bn

—

Balance-sheet debt

A$125.5m

Debt-free

—

R&D intensity (%)

0——

Recent Developments

--

Company Snapshot

2001

Founded

Sydney, Australia

Headquarters

SWOT Analysis

Strengths

  • Long-run treaty-arbitration capability. FY25 treaty wins returned 9.0x and 6.8x MOIC; Green-X v Poland alone contributed A$26.1m of net realised gains.
  • Award survived set-aside in Singapore. On 12 January 2026 the Singapore court rejected Poland's set-aside application against the ECT award, supporting collection.
  • Fund I's early realisations were strong. Twelve concluded cases produced a 30.4% net IRR and 1.7x net MOIC for LPs (to June 2025).
  • Cost base cut sharply. Operating expenses fell 42% from A$19.0m (FY24) to A$11.0m (FY26).
  • The lender has stayed supportive. Northleaf granted serial waivers from June 2025 to September 2026, upsized the facility three times (US$75m to US$100m to US$125m) and extended maturity to 2030.
  • Residual portfolio optionality. There are 37 ongoing cases with A$224m of commitments and A$122m invested (FY26), including a High Court of Australia trademark win awaiting damages.

Weaknesses

  • Negative equity. Net liabilities stood at A$53.6m at 30 June 2026, against net assets of A$188.9m two years earlier.
  • Lender-senior economics. Repayment is the greater of principal plus PIK or 2x drawn principal, and Northleaf keeps 25% of residual gross proceeds after repayment.
  • Severe concentration. The company admits losses were compounded by a large amount of capital committed to a small number of cases.
  • Negligible cash generation. LCM-only cash from concluded investments was A$2.4m in FY26 against A$37.7m deployed.
  • Fair value marks proved unreliable. Cases realised in FY25 were held at 2.8x cost before conclusion but realised 1.8x; FY25 fair value movement was -A$100.1m.
  • Governance thinned out. The board fell to four members with two non-executives; both the CEO and Chair are large shareholders.

Opportunities

  • Successful appeals. A$66m invested sits in cases under appeal (A$33m carried value). Wins would reverse write-downs.
  • Collection of the Polish awards. This is now mainly an enforcement question rather than a litigation question.
  • Recovery from the Gladstone solicitors. A costs assessment and a negligence claim are under way over the A$30.8m write-off.
  • Compensation claim over the Dubai probe. LCM says it is reviewing legal options to be compensated in full.
  • Unrecognised tax assets. Gross tax losses of A$62.3m (A$18.1m tax effect) are unrecognised and could shelter future gains if continuity tests are met.
  • Trademark damages. The High Court of Australia win (A$3.3m invested) proceeds to quantification.

Threats

  • Going-concern material uncertainty. This depends on satisfying the remaining conditions precedent and on forecast realisations.
  • Further case losses. Losses continued after year-end, for example the A$2.9m insolvency claim on 8 October 2026.
  • Fund I clawback could exceed the provision. A A$20.4m provision has been booked; a A$6.6m performance-fee receivable was also derecognised.
  • Under-insured adverse costs. The contingent range was A$4–8m at December 2025, with a A$4.2m provision at FY26.
  • Covenant test from 31 December 2027. It falls under the new run-off covenant framework.
  • Delisting or insolvency. A 1.53p share price and a roughly £1.7m market capitalisation leave equity exposed to delisting or insolvency outcomes (analyst inference).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
1 Apr 2025Outcome of commercial arbitration investment: lossStart of the 2025 loss cluster (A$2.6m invested)
13 May 2025Statement on media reports of a Dubai corruption and money-laundering probeLCM denies knowledge; Fund III first close derailed
19 Jun 2025Adverse judgment in funded case; trading updateFund III marketing paused; shares slide
23 Jun 2025TR-1: Perpetual crosses a voting-rights thresholdRegister churn
8 Sep 2025Notice of FY25 results—
15 Sep 2025Gladstone Ports class action terminated; A$30.8m write-off; formal strategic review with LuminisMajor capital loss; going-concern pressure
1 Oct 2025FY25 results: loss A$72.9m; net assets A$114.4m; covenant waiver to 30 December 2025 (+2.00% margin, 1.50% fee)First full-year loss; material uncertainty
1 Oct 2025UK High Court judgment against funded party (A$20.6m LCM capital; £26.5m fair value)Shares down about 60% to 10.6p
2 Oct 2025TR-1 holding notificationRegister churn
6 Oct 2025Update on commercial arbitration loss (appeal route)Further write-down
13 Oct 2025Exercise of awardsMinor
21 Oct 2025AGM postponedGovernance signal
19 Nov 2025Annual report posted—
26 Nov 2025Strategic review update: credible counterparties; lender covenant reliefHope of a transaction
27 Nov 2025AGM results—
24 Dec 2025Adverse costs order in class action (Queensland Electricity; about A$32.4m total)A$12.9m uninsured LCM exposure
30 Dec 2025Covenant waiver extendedLender support
12 Jan 2026Singapore court rejects Poland's set-aside of the ECT award (Green-X)Supports the receivable
2 Feb 2026Facility increased US$75m to US$100m; waiver to 1 March 2026More leverage
2 Mar 2026Covenant waiver extended—
11 Mar 2026High Court of Australia win in trademark dispute (A$3.3m invested)Rare positive; damages to be quantified
17 Mar 2026Adverse judgment, Australian commercial claim (A$1.4m)Loss
25 Mar 2026Notice of H1 results and trading update—
31 Mar 2026H1 FY26: loss A$107.8m; net assets A$5.6mEquity almost exhausted
15 Apr 2026Covenant waiver extended—
1 Jun 2026Waiver to 30 June 2026; two negative case developments (about A$9m invested)Material write-downs flagged
30 Jun 2026Covenant waiver extended—
3 Jul 2026Permission to appeal competition claim refused; A$1.5m written offLoss
31 Jul 2026Covenant waiver extended—
1 Sep 2026Covenant waiver extended—
30 Sep 2026FY26 results: loss A$165.7m; net liabilities A$53.6m; review ends with no transaction; run-off; Northleaf US$125m amendment to 2030Equity effectively subordinated
8 Oct 2026Australian insolvency claim lost (A$2.9m balance-sheet capital; ATE in place)Continuing losses

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

5 charts
Income Statement: Revenue & Gross Profit: Gross profit, historical-cost basis as originally reported, incl. third parties was AUD 31.1 Mn in FY2022.
Litigation Capital Management Limited — Income Statement: Revenue & Gross Profit
Series (AUD Mn)FY2022
Gross profit, historical-cost basis as originally reported, incl. third parties31.1

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. LCM, "Full year audited results for the year ended 30 June 2026", RNS, 30 Sep 2026
  2. LCM, "Judgment Delivered in Insolvency Claim", RNS, 8 Oct 2026
  3. LCM, "Permission to Appeal Competition Claim Rejected", RNS, 3 Jul 2026
  4. LCM, "Update on Covenant Waiver, Case & Strategic Review", RNS, 1 Jun 2026
  5. LCM, "Interim results for the HY ended 31 December 2025", RNS, 31 Mar 2026
  6. LCM, "Increase in Credit Facility and Waiver Extension", RNS, 2 Feb 2026
  7. LCM, "Strategic Review Update", RNS, 26 Nov 2025
  8. LCM, "Annual Results for the year ended 30 June 2025", RNS, 1 Oct 2025
  9. LCM, "Class Action Investment and Strategic Review", RNS, 15 Sep 2025
  10. LCM, FY2024 results (17 Sep 2024), FY2023 results (19 Sep 2023), FY2022 results (20 Sep 2022), fair value transition (18 Jul 2023)
  11. Investegate LCM announcement index (accessed Oct 2026)
  12. Secondary: QuotedData (Oct 2025), Stockopedia, Simply Wall St (ownership, Jun 2025), Fidelity factsheet (Apr 2026), Shares Magazine, Law Gazette (Sep 2022), Global Legal Post (Sep 2023), Omni Bridgeway FY26 release (Aug 2026), Burford FY25 release (Feb 2026), TipRanks (Burford financials)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.